98%
921
2 minutes
20
Objective: The aim of this study was to examine the effects of internalized HIV stigma on viral nonsuppression via depressive symptoms, alcohol use, illicit drug use, and medication adherence and investigate whether social support moderates these effects.
Design: Longitudinal observational clinical cohort of patients in HIV care in the US.Methods: Data from the CFAR Network for Integrated Clinical Systems (2016-2019) were used to conduct structural equation models (SEM) to test the indirect effects of internalized HIV stigma on viral nonsuppression through depressive symptoms, illicit drug use, alcohol use, and medication adherence. Moderated mediation with an interaction between social support and internalized HIV stigma was examined.
Results: Among 9574 individuals included in the study sample, 81.1% were men and 41.4% were black, non-Hispanic. The model demonstrated good fit (root mean square error of approximation = 0.028; standardized root means square residual = 0.067). The overall indirect effect was significant [b = 0.058; se = 0.020; β = 0.048; 95% confidence interval (95% CI) = 0.019-0.098], indicating that internalized HIV stigma's impact on viral nonsuppression was mediated by depressive symptoms, illicit drug use, and medication adherence. An interaction was observed between internalized HIV stigma and social support on alcohol use; however, there was no moderated mediation for any of the mediators.
Conclusion: Internalized HIV stigma indirectly impacts viral nonsuppression through its effects on depressive symptoms, illicit drug use, and medication adherence. Social support may buffer the impact, but more research is needed. Understanding the pathways through which internalized stigma impacts viral suppression is key to improving health of people with HIV.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666411 | PMC |
http://dx.doi.org/10.1097/QAD.0000000000003999 | DOI Listing |
Antiviral Res
September 2025
Department of Immunology and Pathogen Biology, Key Laboratory of Pathogen and Host-Interactions, Ministry of Education, School of Medicine, Tongji University, Shanghai, 200331, China. Electronic address:
DMBT1 is a large scavenger receptor cysteine rich (SRCR) B protein that has been reported as a tumor suppressor gene and a co-receptor for HIV-1 infection. Here, we found DMBT1 is a major mucosal protein bound to SARS-CoV-2. Overexpression of DMBT1 in 293T cells may enhanced infection by SARS-CoV-2 in ACE2 dependent manner.
View Article and Find Full Text PDFHIV Med
September 2025
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Introduction: Human immunodeficiency virus (HIV) remains a significant global health problem, and the number of new cases is increasing in Central Asia, including Kazakhstan. This study aimed to examine the association of a range of demographic, physical health and psychosocial factors with the mental health of people living with HIV in Kazakhstan, applying the two-continua model of mental health, which holds that mental wellbeing and mental illness are two distinct continua that are interrelated in their contributions to overall mental health. The study findings can inform future interventions aimed to prevent mental illness and promote the mental wellbeing of people living with HIV.
View Article and Find Full Text PDFJ Acquir Immune Defic Syndr
September 2025
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Background: Anti-lesbian, gay, bisexual, transgender, and/or queer (LGBTQ+) legislation has dramatically increased in the United States. These laws limit the rights of sexual and gender minoritized (SGM) youth, but their health effects remain understudied. We estimated how a hypothetical intervention setting states to have more equitable LGBTQ+-related policies would affect individual-level pre-exposure prophylaxis (PrEP) use among SGM youth and young adults, and whether internalized stigma mediates this effect.
View Article and Find Full Text PDFStigma Health
October 2024
Graduate School of Public Health, University of Puerto Rico.
Self-stigma among persons with substance use disorders (SUDs) represents a significant barrier to patient recovery. Numerous studies have identified that experienced or enacted stigma deters people from seeking health treatment, impacting their well-being. Considering that chronic exposure to SUD-related stereotypes is associated with the internalization of such stereotypes and that self-stigma has been linked to lower levels of self-efficacy, the present study examined the association of experienced or enacted substance use stigma, self-efficacy, and self-stigma with emotional well-being among Latinxs with SUD.
View Article and Find Full Text PDFBrain Sci
July 2025
Department of Life Science, Health, and Health Professions, Link Campus University, 00165 Rome, Italy.
: Despite medical advances, stigma remains a major challenge for people living with HIV (PLWH). This study examined clinical, sociodemographic, and psychological predictors of HIV-related stigma, and explored whether affective temperament moderates the impact of depression on stigma. : This cross-sectional observational study included 97 PLWH attending a tertiary infectious disease unit in Rome, Italy.
View Article and Find Full Text PDF